Lpath's (LPTN.OB) Lpathomab treatment performed well in tests on mice with partially severed...

|About: Lpath Inc. (LPTN)|By:, SA News Editor

Lpath's (LPTN.OB) Lpathomab treatment performed well in tests on mice with partially severed spinal cords. Lpath says Lpathomab "reverses much of the damage caused by trauma to the nervous system," bringing scientists closer to finding a treatment for spinal cord injury. The results of the study have been published in the American Journal of Pathology. (PR)